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Induction of "wire-loop" lesions by murine monoclonal tgG3 cryoglob-
ulius. We have recently demonstrated that an IgG3 rheumatoid factor
(RF) monoclonal antibody (mAb), clone 6-19, derived from unmanipu-
lated autoimmune MRL/MpJ-lpr/lpr mice, is able to generate cryoglob-
ulins via a non-immunological IgG3 Fc interaction, and to induce an
acute glomerulonephritis associated with cryoglobulinemia. Using this
experimental model, we have characterized the glomerular lesions
induced by the 6-19 RF monoclonal cryoglobulin, in particular the
ultrastructural localization of the cryoglobulin deposits. Although their
initial localization was confined to the mesangium, the 6-19 cryoglobu-
lins were progressively accumulated in the subendothelial spaces of
glomerular capillary walls, leading to the formation of glomerular
lesions resembling the "wire-loop" lesion characteristically described
for lupus nephritis. In addition, we have found that identical glomerular
"wire-loop" lesions were induced by the 6-19-J558 hybrid antibody,
composed of the 6-19 y3 heavy chain and J558 Al light chain, which
loses the RF activity, but retains the cryoglobulin activity. These
results strongly suggest that the direct deposition of IgG3 cryoglobulins
by itself, without involvement of immune complex formation, results in
the generation of the classical "wire-loop" lesion characteristic of lupus
nephritis. In addition, we have found that similar "wire-loop" lesions
were generated by one anti-DNA mAb derived from (NZB X NZW)F1
hybrid mice, and two of four IgG3 mAb of unknown specificities,
derived from MRL/MpJ-/pr/lpr mice. The absence of significant glomer-
ular lesions, in spite of large amounts of cryoglobulins, in mice
receiving two IgG3 mAb suggests the importance of physicochemical
property of cryoglobulins to provoke glomerular lesions.
Cryoglobulins are molecules of Ig which precipitate at low
temperature in vitro and redissolve upon warming [1—3]. They
are encountered in a number of pathological conditions, includ-
ing lymphoproliferative diseases, autoimmune diseases, such as
systemic lupus erythematosus and rheumatoid arthritis, and a
number of microbial, viral and parasitic infections. Their pres-
ence is related to a wide variety of pathological manifestations:
Raynaud's phenomenon, arthritis and glomerulonephritis.
Cryoglobulinemia has been described in a murine strain, MRL/
MpJ-/pr/lpr, in which animals spontaneously develop an au-
toimmune lupus-like syndrome characterized by acute diffuse
glomerulonephritis [4]. Serological abnormalities include ex-
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tremely high amounts of cryoglobulins, with a striking predom-
inance of the IgG3 subclass [5], and elevated titers of circulating
immune complexes, probably related to the production of
rheumatoid factors (RF) [4, 6, 7].
To elucidate the immunopathological mechanisms involved
in the cryoglobulin-associated tissue lesions, we have devel-
oped a model of murine cryoglobulinemia: the injection of
hybridoma cells secreting an IgG3 RF monoclonal antibody
(mAb) with cryoglobulin activity, clone 6-19, derived from
MRL/MpJ-/pr//pr mice, induced cryoglobulinemia associated
with a remarkable pathology (skin leucocytoclastic vasculitis
and glomerulonephritis) [8]. More recent studies on a 6-l9-J558
hybrid mAb, clone L8D, which loses the RF activity but retains
the cryoglobulin activity, have shown that both RF and cryo-
globulin activities are required for the development of skin
vasculitis, but that cryoglobulin activity, associated with the y3
constant region, alone is sufficient to cause glomerular lesions
[9]. In the present study, the glomerular lesions induced by both
cryoglobulin-generating IgG3 mAb, 6-19 RF and L8D non-RF,
have been examined at the ultrastructural level to determine the
exact intraglomerular location of the cryoglobulin deposit and
their fine structures. In particular, we have tried to evidence the
presence of so-called "wire-loop" lesions, that is, subendo-
thelial accumulation of electron-dense deposits, a histological
criterion considered typical of lupus nephritis [10-12]. In addi-
tion, we have determined the nephritogenic activity of other
IgG3 monoclonal cryoglobulins without RF activity.
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Methods
Mice
BALB/c and NZW mice were purchased from Bomholtgard
Ltd., Ry, Denmark, and MRL/MpJ- +1+ mice from the Jackson
Laboratories, Bar Harbor, Maine, USA. (MRL/MpJ-+/+ x
BALB/c)F1 (MRL x BALE) and (NZW x BALB)F1 mice were
bred in our own animal facilities.
Monoclonal IgG3 cryoglobulin-generating antibodies
The IgG3 6-19 anti-IgG2a RF mAb and four other IgG3 mAb
of unknown specificity (2-2G, 9-20, 9-44, 9-83) with cryoglobu-
lin activity were obtained from unmanipulated MRL/MpJ-lpr/
lpr mice as described previously [5, 8]. The IgG3 6-19-J558L
hybrid mAb, clone L8D, was established by fusion of the 6-19
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hybridoma with J558L myeloma cells secreting J558 Al light
chains as previously described [9]. This L8D hybrid mAb
composed of 6-19 73 heavy chain and J558 Al light chain has no
more RF activity, but retains the cryoglobulin activity [9]. An
lgG3 anti-DNA mAb (SH-11) was derived from (NZB x
NZW)F1 hybrid mice. Isoelectric points (p1) of mAb were
determined by analytical isoelectric focusing gel electrophore-
sis as previously described [13]. Hybridoma cells (10) were
injected intraperitoneally into MRL x BALB (for hybridomas
of MRL/MpJ-lpr/lpr origin) or (NZW x BALB)F1 (for the
SH- 11 hybridoma) mice pretreated with pristane.
Isolation of cryoglobulins
Blood sampies collected from retroorbital plexus were al-
lowed to clot at 37°C for two hours. Aliquots of 100 p1 of sera
were placed in glass tubes at 4°C for three days. Then, samples
were centrifuged at 2,500 rpmfor 10 minutes. The supernatants
were preserved and the precipitates were washed four times
with cold PBS (pH 7.3) by centnfugation and finally solubilized
in 4 M urea in the same volume as the original sample.
Serological assays
Levels of IgG3 subclass in sera or cryoglobulins were quan-
titated by ELISA as described previously [5]. 6-19 mAb RF
activities in sera were measured by ELISA with a modification
[9] of the method of Wolfowicz et al [14]. Results are expressed
as optical density at 405 nm. Anti-DNA activity was determined
by ELISA [15].
Histopathology
Blocks of all major organs were obtained at autopsy, and
sections were stained with hematoxylin and eosin, periodic acid
Schiff, and phosphotungstic acid reagent to evidence fibrin
deposition. Kidneys were studied for the deposition of lgG, C3
and fibrinogen by direct staining with fluorescein-isothiocy-
anate-conjugated rabbit anti-mouse IgG, goat anti-mouse C3 or
anti-rat fibrinogen (Cappel Laboratories). Parts of the kidneys
were fixed in 20% glutaraldehyde, embedded in Epon and
stained with osmium for ultrastructural examination, performed
with a Philips EM 400 T electron microscope (Rotterdam,
Holland).
Statistical analysis
Statistical analysis was performed with the Wilcoxon two-
samples test. Probability values >5% were considered insignif-
icant.
Results
"Wire-loop' '-like glomerular lesions induced by 6-19 lgG3
mAb with cryoglobulin and RF activities
MRL x BALB mice were sacrificed at five or eight days after
intraperitoneal injection of iO 6-19 hybridoma cells. Serum
levels of IgG3 were in a range of 0.7 to 4.2 mg/mi in 6-19
hybridoma cell-injected mice (Table 1). Substantial amounts of
cryoglobulins, which ranged from 14 to 68 g/ml were recover-
able from sera from all 6-19-injected animals. As described
previously [8], cryoprecipitates were composed almost exclu-
sively of IgG3 (data not shown). IgG3 anti-IgG2a RE activities
were present in the sera of all 6-19-injected mice at dilutions of
Table 1. Serum levels of IgG3, cryoglobulins and anti-IgG2a RF in
mice injected with 6-19 or L8D hybridoma cellsa
Day at
mAb sacrifice IgG3 Cryoglobulins RF
6-19 (7.10)' Day 5 1.88 0.76 (5)° 17 3 1.081 0.137
Day 8 3.25 0.59 (5) 43 17 1,388 0.111
L8D (7.00) Day 11—17 2.11 0.75 (9) 15 5 0.059 0.007
Control" 0.06 0.01 (5) <0.1 0.051 0.012
a o7 hybridoma cells were injected intraperitoneally into pristane-
pretreated 3-month-old MRL x BALB female mice on day 0. Serum
levels of IgG3 (mg/mi), cryoglobulins (g/ml) and IgG3 anti-IgG2a RF
activity (0D405 nm) at sacrifice were determined by ELISA (mean 1
SD)
b 1 of mAb
C Number of mice studied
"Pristane-treated MRL x BALB mice of the same age and sex
1/2,500. Notably, all three serological parameters in mice sac-
rificed at day 8 were significantly higher than those in mice
sacrificed at day 5 (P < 0.01). Neither cryoglobulin activities
nor IgG3 anti-IgG2a RF activities were detectable in sera of
control pristane-treated mice.
All treated animals showed striking kidney modifications
consisting in a diffuse glomerulonephritis. By light microscopy,
in mice sacrificed at day 5, predominant glomerular lesions
were characterized by exudation of polymorphonuclear leuko-
cytes and a mild increase in glomerular cellularity (Fig. 1A). In
mice sacrificed at day 8, exudation and glomerular hypercellu-
larity were less prominent, but instead, a number of glomeruli
showed PAS-positive deposits along the glomerular capillary
walls, resembling "wire-loop" lesions (Fig. lB). In a further
advanced case, a disseminated plugging of glomerular capillar-
ies by voluminous PAS-positive giant hyaline thrombi, often
obstructing the capillary lumen was noted (Fig. IC). Immuno-
fluorescence examination revealed glomerular deposits of IgG,
which was primarily IgG3 as described previously [8], and C3 in
the mesangium at the initial phase, later also present along some
capillary walls (Fig. 2A-C). The phosphotungstic acid and
immunofluorescence stainings revealed the presence of sub-
stantial amounts of fibrin-fibrinogen admixed in the thrombi
(Figs. 1D and 2D). An inverse relation between quantity of
glomerular deposits and extent of glomerular cellularity was
conspicuous. The extent of glomerular lesions was well corre-
lated with serum levels of IgG3 and cryoglobulins. Rarely, some
arterioles contained deposits in their lumens, yet without any
cell infiltrate. Occasional protein casts were noticed in tubular
lumina.
Electron microscopic examination was performed in mice
sacrificed at day 8 to determine the exact location of the
deposits in the glomerular structures. All glomeruli showed a
diffuse obstruction of practically all capillary loops by amor-
phous protein deposits. Their location was not only intracapil-
lary: some endothelial cells were separated from the basement
membrane by massive electron-dense deposits moulding the
contours of the peripheral capillary loops, reproducing the
aspect of typical "wire-loop" lesions observed in diffuse lupus
nephritis (Fig. 3). In this advanced stage, glomeruli showed a
minimal mesangial cell proliferation and no conspicuous mesan-
gial deposits. By high power magnification (x 22,000) of the
r
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Fig. 1. Histological findings of glomerular
lesions in MRL x BALB mice after the
intraperitoneal injection of 6-19 IgG3 RF
hybridoma cells. A. Representative
histological appearance of glomerular lesions
in mice sacrificed at day 5. Note the
infiltration of polymorphonuclear leukocytes
and increased glomerular cellularity (HE,
x 145). B. Representative histological
appearance in mice sacrificed at day 8.
Leukocyte exudation is less prominent. Note
the presence of PAS-positive deposits along
the glomerular capillary walls, resembling
"wire-loop" lesions (PAS, x 145). C. Far
advanced glomerular lesions observed in some
mice exhibiting higher concentrations of IgG3
and cryoglobulins sacrificed 8 days after
injection of 6-19 IgG3 RF hybridoma cells.
Their glomerular lesions are characterized by
the voluminous deposition of PAS-positive
materials which nearly occlude the capillary
lumen (PAS, x 145). D. The demonstration of
substantial amounts of fibrin admixed in
intraluminal deposits of glomeruli in mice
sacrificed at day 8 (phosphotungstic acid
staining, x290).
subendothelial and intracapillary deposits, the typical crystal-
loid or fibrillar aspect with cylindrical or tubular structures
described in human type II IgM-IgG cryoglobulin deposits [16,
17] was not present. No basement membrane duplication due to
mesangial cell interposition was seen.
"Wire-loop' '-like gloi'nerular lesions induced by L8D IgG3
hybrid mAb with cryoglobulin, but not RF activity
To study whether the immune complex formation plays a role
in the generation of "wire-loop"-like lesions observed in mice
injected with 6-19 RF hybridoma, we have analyzed glomerular
lesions induced by L8D mAb, composed of 6-19 y3 heavy chain
and J558 Al light chain, which retains the cryoglobulin activity,
but loses the RF activity. After an average of 15 days after L8D
hybridoma injection, serum levels of IgG3 and cryoglobulins
were quite comparable to those found in mice injected with 6-19
hybridoma cells (Table 1). However, no significant activities of
IgG3 anti-IgG2 were detectable in their sera.
Renal lesions induced by the L8D mAb were essentially
identical to those caused by 6-19 mAb; the kidneys of all
animals showed a diffuse glomerulonephritis associated with
leucocytic exudation, "wire-loop" lesions (Fig. 4) and intra-
capillary deposition of hyaline thrombi, depending on the
progression of glomerular damages. Electron microscopic ex-
amination again revealed the massive subendothelial deposits
identical to those seen in mice injected with the 6-19 hybridoma
(not shown).
Induction of "wire-loop' '-like glomerular lesions by three of
five other IgG3 monoclonal cryoglobulins
Since the nephritogenic activity of the 6-19 RF cryoglobulin is
determined only by its cryoglobulin activity, we have studied
the development of glomerular lesions by five other IgG3
monoclonal cryoglobulins without RF activity: one with anti-
DNA activity from (NZB x NZW)FI hybrid mice (SH-1 1) and
four of unknown specificity, but without RF activity [5, 8], from
MRL/MpJ-lpr//pr mice (2-2G, 9-20, 9-44, 9-83). Three of these
five mAb studied (SH-11, 9-20 and 9-83) induced hyaline
thrombi with "wire-loop"-like glomerular lesions (Table 2). In
contrast, two other IgG3 mAb (2-2G and 9-44) failed to cause
significant glomerular lesions in all of the injected animals, in
spite of the occasional presence of PAS-positive cryoprecipi-
tates in capillary lumens of the glomeruli (Fig. SA). Similar
precipitates were also seen in lumens of peritubular capillaries
(Fig. SB) and in arterioles without any significant inflammatory
reaction. Although serum levels of IgG3 and cryoglobulins
varied in mice receiving different hybridomas, their levels in
mice injected with both non-pathogenic IgG3 mAb at sacrifice
were higher than in those injected with pathogenic clones. This
was further confirmed when serum levels of IgG3 were sequen-
tially determined after the injection of hybridoma cells secreting
pathogenic IgG3 mAb, 6-19, SH-1 1 or 9-83, or non-pathogenic
mAb, 2-2G; serum IgG3 levels in mice injected with the 2-2G
hybridoma were consistently higher than those in mice injected
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Fig. 2. Immunofluorescence findings of
glomerular lesions in MRL x BALB mice
after the intraperitoneal injection of 6-19 lgG3
RF hybridoma cells. A. Heavy IgG deposits in
glomerulus from a mouse exhibiting the
lowest concentration of IgG3 (0.7 mg/mI) and
cryoglobulins (14 g/ml), sacrificed at day 5.
Note diffuse mesangial deposits and
occasional deposits along the glomerular
capillary walls (x330). B-D. Marked
glomerular IgO (B), C3 (C) and fibrinogen (D)
deposits in mice sacrificed at day 8 (x330).
with nephritogenic hybridoma cells (Table 3). This indicates
that the absence of glomerular lesions in mice receiving 2-2G
and 9-44 hybridoma cells was not due to a limited secretion of
IgG3 mAb in vivo.
Since it has been proposed that the charge characteristics of
antibodies may play an important role in glomerular localization
of immune complexes [18], we have compared the p1 of
nephritogenic IgG3 mAb with those of non-nephritogenic ones.
Although the p1 of one of the nephritogenic mAb, SH- 11, was
alkaline (8.30), other IgG3 rnAb were focused in the neutral pH
range (6.75 to 7.60), and no clear-cut differences were observed
in p1 between nephritogenic and non-nephritogenic IgG3 mAb
(Tables I and 2).
Discussion
In the present study, we have shown that a murine IgG3 RF
mAb with the cryoglobulin activity is able to induce massive
subendothelial deposits, that is, so-called "wire-loop" lesions,
in glomerular capillary walls typically described in diffuse
proliferative lupus nephritis in humans [10—12]. The generation
of similar glomerular lesions by the 6-19-J558 hybrid antibody,
which loses the RF activity, but retains the cryoglobulin activ-
ity, strongly suggests that the "wire-loop" lesion can be in-
duced by direct localization of IgG3 cryoglobulins by itself,
without involvement of immune complex formation. In addi-
tion, three other IgG3 monoclonal cryoglobulins with different
specificities, including one anti-DNA autoantibody, were
shown to induce similar "wire-loop"-like glomerular lesions.
To our knowledge this is the first experimental model in which
glomerular lesions resemble the "wire-loop" lesion of lupus
nephritis.
As we have previously demonstrated, murine IgG3 molecules
exhibit a unique physicochemical property of self-association
by means of their Fe portion, involved in the generation of
cryoglobulins, independently of their antibody specificities [5,
8, 19]. In fact, the monoclonal IgG3 is the sole IgG recoverable
in cryoprecipitates isolated from the sera of mice injected with
the IgG3-secreting hybridoma including the 6-19 RF mAb [8,
19]. The generation of "wire-loop" lesions by the deposition of
L8D mAb lacking the RF autoantibody activity and the devel-
opment of similar glomerular lesions by the 6-19 RF mAb in
Ig-deficient mice [9] further support the idea that the direct
localization of 6-19 monoclonal cryoglobulins is responsible for
the development of "wire-loop" lesions. This notion is in
keeping with the fact that ultrastructural studies on the 6-19
cryoglobulin deposits failed to show the crystalloid structure,
which has been characteristically described for the cryoglobu-
lins from patients with type II mixed IgM-IgG cryoglobulins,
but not in type I monoclonal cryoglobulins [16, 17].
According to Lockwood [20], the glomerular localization of
cryoglobulins can be favored by a high endocapillary concen-
tration of cryoglobulins, occurring as a result of the glomerular
filtration process, which increases the viscosity of the capillary
contents due to fluid loss. However, the question that remains
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Fig. 3. Electron microscopical findings in
glomerular lesions in MRL x BALB mice 8
days after the intraperitoneal injection of 6-19
IgG3 RF hybridoma cells (A: x2275; B:
x5825). Note massive subendothelial electron-
dense deposits along glomerular capillary
walls corresponding to the "wire-loop"
lesions observed in the histological
examination, and marked swelling of
endothelial cells (stars) which are detached
from the glomerular basement membrane
(arrows).
to be answered is: how can our IgG3 cryoglobulins be localized
in the subendothelial spaces? Since the initial site of IgG3
localization is the mesangium, as shown in mice receiving a
single dose of 6-19 mAb [211, overloading the clearance capac-
ities of the mesangium, as a result of continuous secretion of
IgG3 cryoglobulins by implanted hybridoma cells, may lead to
their deposition through the fenestrated endothelium of glomer-
ular capillaries between the endothelial cell and the basement
membrane. At present, it is unknown whether any factors
produced by mesangial cells or infiltrating inflammatory cells
following the cryoglobulin deposition are involved in the pro-
cess of subendothelial localization of IgG3 cryoglobulins. How-
ever, it is possible that cationic proteins, released locally by
activated platelets and/or neutrophils during the inflammatory
reaction occurring in the initial phase, may neutralize anionic
sites of glomerular capillary walls. This could favor the depo-
sition of cryoglobulins in subendothelial spaces. The possible
direct binding of the 6-19 mAb to glomerular capillary walls,
leading to subsequent subendothelial deposition, is unlikely,
because of the absence of in vivo binding of passively trans..
ferred 6-19 RF mAb with the glomerular basement membrane
[21].
A frequent hallmark of cryoglobulinemic glomerulopathy in
humans is the development of a membranoproliferative glomer-
ulonephritis which is characterized by an interposition of
mesangial cells and basement membrane duplication [16, 22—
0'
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Fig. 4. Representative histological
appearance of glomerular lesions in MRL x
BALB mice 14 days after the intraperitoneal
injection of L8D lgG3 hybridoma cells. Note
the presence of marked PAS-positive deposits
along the glomerular capillary walls,
resembling "wire-loop" lesions (A: PAS,
x335; 8: PAS, x840).
25]. In our experimental model, no such lesions were observed.
However, since the kidneys ewre examined only after a rela-
tively short time of cryoglobulin deposition, that is, a maximum
of 17 days, a longer time span might allow such lesions to
develop. Alternatively, certain types of cryoglobulins, because
of their unique conformations and physicochemical properties,
may rather produce "wire-loop" lesions, but not lesions char-
acteristic of membranoproliferative glomerulonephritis.
It should be emphasized that although the nephritogenic
activity of the 6-19 RF mAb has been shown to be determined
only by its cryoglobulin activity [91, not all IgG3 cryoglobulins
were able to provoke glornerular injuries even in the presence of
intracapillary precipitates. The lack of correlation of the sever-
ity of glomerular lesions with serum levels of cryoglobulins
suggests an importance of the qualitative aspect of cryoglobu-
lins for the induction of glomerular lesions. This notion is
consistent with the fact that in humans, cryoglobulinemia is not
always associated with glomerulopathies [25, 261. At present,
we do not know what is the molecular basis for the nephrito-
genic activity of IgG3 monoclonal cryoglobulins. However,
since our recent sequence analysis did not show any mutation in
the heavy chain constant region of the pathogenic 6-19 RF mAb
(T. Berney et al, In,' Immunol, in press), and since the V region
sequences can markedly influence the cryoglobulin activity of
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Fig. 5. Representative histological
appearance of kidneys in MRL x BALB mice
11 days after the intraperitoneal injection of
2-2G IgG3 hybridoma cells. Note the presence
of intracapillary precipitation of PAS-positive
materials (arrows) in the glomeruli (A).
Similar precipitates are seen in lumens of
peritubular capillaries without apparent
inflammatory reaction (B).
Table 2. Serum levels of 1g03 and cryoglobulins, and development
of glomerular lesions in mice injected with various IgG3 hybridoma
celisa
mAb
Day at
sacrifice IgG3 Cryoglobulins
Kidney
lesions
SH-ll (830)b Day 7—11 2.2 1.0 (7)C 6 2 7/7
9-20 (7.15) Day 7—13 5.4 1.3 (5) 534 60 5/5
9-83 (7.15) Day 10—11 2.9 0.8 (5) 31 7 4/5
2-2G (7.60) Day 10—17 32.0 6.4 (5) 1560 760 0/5
9-44 (6.75) Day 9—12 14.8 4.4 (4) 660 70 0/4
a l0 hybridoma cells were injected intraperitoneally into 3-month-
old (NZW x BALB)F1 for SH-1 1 and MRL x BALB female mice for
others. Serum levels of IgG3 (mg/mi) and cryoglobulins (pg/mI) at
sacrifice were determined by ELISA (mean 1 SD). Note that none of
the sera exihibited significant RF activities, and that only sera from
mice injected with SH-l I hybridoma cells had high titers of anti-DNA
activities (data not shown)b p1 of mAb
C Number of mice studied
IgG3 [19], the presence of unique amino acid residues in the V
region could account for the differences in nephritogenicity
among various IgG3 monoclonal cryoglobulins.
Although the precise role of IgG3 cryoglobulins in the patho-
genesis of murine lupus nephritis remains to be determined, the
selective enrichment of IgG3 in cryoglobulins spontaneously
developing in autoimmune MRL/MpJ-lpr/lpr mice [5] and the
retardation of murine lupus nephritis by the transfer of the xid
(X chromosome-linked immune deficiency) gene [27, 28], which
causes a defect of 1gM and IgG3 production, may suggest that
IgG3 cryoglobulins participate in the glomerulonephritis of
MRL/MpJ-!pr/Ipr mice. In fact, recent studies on MRL x (MRL
x C3H) backcross mice expressing the lpr gene have shown a
good correlation of IgG3 production with the development of
glomerular lesions [29]. Finally, it is worth noting that human
IgG3 have a self-associating activity similar to that of murine
IgG3 [30, 31], and that IgG3 is occasionally enriched in human
mixed cryoglobulins [32].
In conclusion, we have demonstrated that the "wire-loop"
lesions, which are thought to be characteristic of lupus nephri-
tis, can be induced by murine IgG3 monoclonal cryoglobulins
with various specificities. Although our results do not imply
that cryoglobulins are the only cause to generate the "wire-
loop" lesion, in certain cases of lupus, autoantibodies with a
Table 3. Kinetic studies on serum levels of IgG3 in mice injected
with various IgG3 hybridoma cellsa
mAb Day 3b Day 6 Day 9 Day 12
6-19 0.5 0.1 1.9 0.5 3.5 0.8C
SH-11 0.4 0.1 1.2 0.3 2.3 0.3C
9-83 0.5 0.2 2.2 0.9 2.9 0.7c
2-2G 1.0 0.3 3.1 2.6 14.3 5.1 25.0 3.6
a l0 hybridoma cells were injected intraperitoneally into 3-month-
old (NZW x BALB)F1 for SH-11 and MRL x BALB female mice for
others. Serum levels of IgG3 (mg/mi) were determined by ELISA 3, 6,
9 and 12 days after injection of hybridoma cells (mean of 3 to 4 mice
1 SD). Mean concentrations of serum IgG3 before the injection of
hybridoma cells were 0.1 0.1 mglmlb Days after the hybridoma injection
C Mice injected with 6-19 hybridoma were sacrificed at day 8, and
those injected with SH-l 1 or 9-83 hybridoma were sacrificed before day
12
particular cryoglobulin activity may participate in the genera-
tion of the classical "wire-loop" lesion by their direct deposi-
tion without the involvement of immune complex formation.
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